Gene panel testing of 5589 <i><scp>BRCA</scp>1/2</i>‐negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian CancerJan Hauke, Eric Hahnen, Gunnar Schmidt et al.|Cancer Medicine|2018Cited by 168
Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in <i>RAD51C</i> and <i>RAD51D</i>Xin Yang, Mark E. Robson, Honglin Song et al.|JNCI Journal of the National Cancer Institute|2020Cited by 163
Individuals with FANCM biallelic mutations do not develop Fanconi anemia, but show risk for breast cancer, chemotherapy toxicity and may display chromosome fragilityIrene Catucci, Paolo Peterlongo, Ana Osório et al.|Genetics in Medicine|2017Cited by 93